1
|
Eilber FC, Rosen G, Nelson S, Selch M,
Dorey F, Eckardt J and Eilber FR: High-grade extremity soft tissue
sarcomas: factors predictive of local recurrence and its effect on
morbidity and mortality. Ann Surg. 237:218–226. 2003. View Article : Google Scholar : PubMed/NCBI
|
2
|
Fisher C: Synovial sarcoma. Ann Diagn
Pathol. 2:401–421. 1998. View Article : Google Scholar
|
3
|
Amary MF, Berisha F, Bernardi Fdel C,
Herbert A, James M, Reis-Filho JS, Fisher C, Nicholson AG,
Tirabosco R, Diss TC and Flanagan AM: Detection of SS18-SSX fusion
transcripts in formalin-fixed paraffin-embedded neoplasms: analysis
of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic
tools for synovial sarcoma. Mod Pathol. 20:482–496. 2007.
View Article : Google Scholar
|
4
|
Fletcher CDM, Unni KK and Mertens F:
Tumours of Soft Tissue and Bone. IARC Press; Lyon: pp. 200–204.
2002
|
5
|
Nagayama S, Katagiri T, Tsunoda T, Hosaka
T, Nakashima Y, Araki N, Kusuzaki K, Nakayama T, Tsuboyama T,
Nakamura T, Imamura M, Nakamura Y and Toguchida J: Genome-wide
analysis of gene expression in synovial sarcomas using a cDNA
microarray. Cancer Res. 62:5859–5866. 2002.PubMed/NCBI
|
6
|
Weiss SW and Goldblum JR: Enzinger and
Weiss’s Soft Tissue Tumors. 5th edition. Mosby Inc.; St. Louis, MO:
pp. 1161–1182. 2008
|
7
|
Haldar M, Randall RL and Capecchi MR:
Synovial sarcoma: from genetics to genetic-based animal modeling.
Clin Orthop Relat Res. 466:2156–2167. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Reya T, Morrison SJ, Clarcke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
9
|
Milas L and Hittelman WN: Cancer stem
cells and tumor response to therapy: current problems and future
prospects. Semin Radiat Oncol. 19:96–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
11
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
12
|
Miki J, Furusato B, Li H, Gu Y, Takahashi
H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S and Rhim JS:
Identification of putative stem cell markers, CD133 and CXCR4, in
hTERT-immortalized primary nonmalignant and malignant tumor-derived
human prostate epithelial cell lines and in prostate cancer
specimens. Cancer Res. 67:3153–3161. 2007. View Article : Google Scholar
|
13
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
14
|
Schatton T, Murphy GF, Frank NY, Yamaura
K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM,
Weishaupt C, Fuhlbrigge RC, Kupper TS, Sayegh MH and Frank MH:
Identification of cells initiating human melanomas. Nature.
451:345–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Li C, Lee CJ and Simeone DM:
Identification of human pancreatic cancer stem cells. Methods Mol
Biol. 568:161–173. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Suvà ML, Riggi N, Stehle JC, Baumer K,
Tercier S, Joseph JM, Suvà D, Clément V, Provero P, Cironi L,
Osterheld MC, Guillou L and Stamenkovic I: Identification of cancer
stem cells in Ewing’s sarcoma. Cancer Res. 69:1776–1781. 2009.
|
17
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
18
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mizrak D, Brittan M and Alison MR: CD133:
molecule of the moment. J Pathol. 214:3–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
21
|
Vander Griend DJ, Karthaus WL, Dalrymple
S, Meeker A, DeMarzo AM and Isaacs JT: The role of CD133 in normal
human prostate stem cells and malignant cancer-initiating cells.
Cancer Res. 68:9703–9711. 2008.PubMed/NCBI
|
22
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations
of cancer stem cells determine tumor growth and metastatic activity
in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Curley MD, Therrien VA, Cummings CL,
Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden
DT, Rueda BR and Foster R: CD133 expression define s a tumor
initiating cell population in primary human ovarian cancer. Stem
Cells. 27:2875–2883. 2009.PubMed/NCBI
|
25
|
Tirino V, Desiderio V, d’Aquino R, De
Francesco F, Pirozzi G, Graziano A, Galderisi U, Cavaliere C, De
Rosa A, Papaccio G and Giordano A: Detection and characterization
of CD133+ cancer stem cells in human solid tumors. PLoS
One. 3:e37692008. View Article : Google Scholar
|
26
|
Terry J and Nielsen T: Expression of CD133
in synovial sarcoma. Appl Immunohistochem Mol Morphol. 18:159–165.
2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Fujii H, Honoki K, Tsujiuchi T, Kido A,
Yoshitani K and Takakura Y: Sphere-forming stem-like cell
populations with drug resistance in human sarcoma cell lines. Int J
Oncol. 34:1381–1386. 2009.PubMed/NCBI
|
28
|
Gibbs CP, Kukekov VG, Reith JD,
Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN and
Steindler DA: Stem-like cells in bone sarcomas: implications for
tumorigenesis. Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
29
|
Okita K, Ichisaka T and Yamanaka S:
Generation of germline-competent induced pluripotent stem cells.
Nature. 448:313–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
30
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
31
|
Wernig M, Meissner A, Foreman R, Brambrink
T, Ku M, Hochedlinger K, Bernstein BE and Jaenisch R: In vitro
reprogramming of fibroblasts into a pluripotent ES-cell-like state.
Nature. 448:318–324. 2007. View Article : Google Scholar : PubMed/NCBI
|
32
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Haraguchi N, Utsunomiya T, Inoue H, Tanaka
F, Mimori K, Barnard GF and Mori M: Characterization of a side
population of cancer cells from human gastrointestinal system. Stem
Cells. 24:506–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
34
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
35
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F,
Maclaughlin DT and Donahoe PK: Ovarian cancer side population
defines cells with stem cell-like characteristics and Mullerian
inhibiting substance responsiveness. Proc Natl Acad Sci USA.
103:11154–11159. 2006. View Article : Google Scholar : PubMed/NCBI
|
36
|
Wu C, Wei Q, Utomo V, Nadesan P, Whetstone
H, Kandel R, Wunder JS and Alman BA: Side population cells isolated
from mesenchymal neoplasms have tumor initiating potential. Cancer
Res. 67:8216–8222. 2007. View Article : Google Scholar : PubMed/NCBI
|
37
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS and Dontu G: ALDH1
is a marker of normal and malignant human mammary stem cells and a
predictor of poor outcome. Cell Stem Cell. 1:555–567. 2007.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Charafe-Jauffret E, Ginestier C, Iovino F,
Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F,
Dutcher J, Brown M, Viens P, Xerri L, Bertucci F, Stassi G, Dontu
G, Birnbaum D and Wicha MS: Breast cancer cell lines contain
functional cancer stem cells with metastatic capacity and a
distinct molecular signature. Cancer Res. 69:1302–1313. 2009.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Kim H, Lapointe J, Kaygusuz G, Ong DE, Li
C, van de Rijn M, Brooks JD and Pollack JR: The retinoic acid
synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate
cancer. Cancer Res. 65:8118–8124. 2005. View Article : Google Scholar : PubMed/NCBI
|
40
|
Huang EH, Hynes MJ, Zhang T, Ginestier C,
Dontu G, Appelman H, Fields JZ, Wicha MS and Boman BM: Aldehyde
dehydrogenase 1 is a marker for normal and malignant human colonic
stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar : PubMed/NCBI
|
41
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak
J, Xing L, Wang H, Liu Z, Su Y, Stass SA and Katz RL: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
42
|
Naka N, Takenaka S, Araki N, Miwa T,
Hashimoto N, Yoshioka K, Joyama S, Hamada K, Tsukamoto Y, Tomita Y,
Ueda T, Yoshikawa H and Itoh K: Synovial sarcoma is a stem cell
malignancy. Stem Cells. 28:1119–1131. 2010.PubMed/NCBI
|
43
|
Tokuzawa Y, Kaiho E, Maruyama M, Takahashi
K, Mitsui K, Maeda M, Niwa H and Yamanaka S: Fbx15 is a novel
target of Oct3/4 but is dispensable for embryonic stem cell
self-renewal and mouse development. Mol Cell Biol. 23:2699–2708.
2003. View Article : Google Scholar : PubMed/NCBI
|
44
|
Maruyama M, Ichisaka T, Nakagawa M and
Yamanaka S: Differential roles for Sox15 and Sox2 in
transcriptional control in mouse embryonic stem cells. J Biol Chem.
280:24371–24379. 2005. View Article : Google Scholar : PubMed/NCBI
|
45
|
Brunk BP, Martin EC and Adler PN:
Drosophila genes posterior sex combs and suppressor two of zeste
encodes proteins with homology to the murine bmi-1 oncogene.
Nature. 353:351–353. 1991. View Article : Google Scholar : PubMed/NCBI
|
46
|
Lessard J and Sauvageau G: Bmi-1
determines the proliferative capacity of normal and leukaemic stem
cells. Nature. 423:255–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
47
|
Haupt Y, Alexander WS, Barri G, Klinken SP
and Adams JM: Novel zinc finger gene implicated as myc collaborator
by retrovirally accelerated lymphomagenesis in E mu-myc transgenic
mice. Cell. 65:753–763. 1991. View Article : Google Scholar : PubMed/NCBI
|
48
|
Mitsui K, Tokuzawa Y, Itoh H, Segawa K,
Murakami M, Takahashi K, Maruyama M, Maeda M and Yamanaka S: The
homeoprotein Nanog is required for maintenance of pluripotency in
mouse epiblast and ES cells. Cell. 113:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
49
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
50
|
Ding XW, Wu JH and Jiang CP: ABCG2: a
potential marker of stem cells and novel target in stem cell and
cancer therapy. Life Sci. 86:631–637. 2010. View Article : Google Scholar : PubMed/NCBI
|